Di Jiang

1.7k total citations
117 papers, 1.0k citations indexed

About

Di Jiang is a scholar working on Surgery, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Di Jiang has authored 117 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Surgery, 39 papers in Oncology and 37 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Di Jiang's work include Prostate Cancer Treatment and Research (19 papers), Bladder and Urothelial Cancer Treatments (16 papers) and Urinary and Genital Oncology Studies (12 papers). Di Jiang is often cited by papers focused on Prostate Cancer Treatment and Research (19 papers), Bladder and Urothelial Cancer Treatments (16 papers) and Urinary and Genital Oncology Studies (12 papers). Di Jiang collaborates with scholars based in Canada, China and United States. Di Jiang's co-authors include Srikala S. Sridhar, Nimira Alimohamed, Peter Chung, Scott North, Yi Lu, Bin Wu, Wei Zhang, Shilpa Gupta, Girish S. Kulkarni and Abhijat Kitchlu and has published in prestigious journals such as Science, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Di Jiang

101 papers receiving 999 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Di Jiang Canada 19 391 325 196 192 121 117 1.0k
Michael H. Rosenthal United States 22 422 1.1× 445 1.4× 212 1.1× 367 1.9× 208 1.7× 78 1.3k
Huanyu Chen China 18 180 0.5× 831 2.6× 382 1.9× 587 3.1× 107 0.9× 63 1.8k
Roni Shouval United States 26 100 0.3× 695 2.1× 310 1.6× 156 0.8× 90 0.7× 109 1.8k
Raffaele De Luca Italy 20 527 1.3× 570 1.8× 251 1.3× 421 2.2× 90 0.7× 61 1.7k
Yuxuan Wu China 19 262 0.7× 135 0.4× 265 1.4× 178 0.9× 144 1.2× 80 1.2k
Fei Xiong China 18 234 0.6× 547 1.7× 146 0.7× 341 1.8× 427 3.5× 46 1.3k
Qingwei Zhang China 22 243 0.6× 335 1.0× 440 2.2× 381 2.0× 176 1.5× 85 1.4k
Wei Fan China 23 260 0.7× 263 0.8× 259 1.3× 378 2.0× 687 5.7× 159 1.7k
Junya Furukawa Japan 18 363 0.9× 335 1.0× 360 1.8× 602 3.1× 59 0.5× 119 1.3k
Frank Kroschinsky Germany 24 86 0.2× 598 1.8× 277 1.4× 209 1.1× 68 0.6× 85 2.3k

Countries citing papers authored by Di Jiang

Since Specialization
Citations

This map shows the geographic impact of Di Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Di Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Di Jiang more than expected).

Fields of papers citing papers by Di Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Di Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Di Jiang. The network helps show where Di Jiang may publish in the future.

Co-authorship network of co-authors of Di Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Di Jiang. A scholar is included among the top collaborators of Di Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Di Jiang. Di Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Di, et al.. (2025). In Other Journals. Science. 387(6736). 838–839. 1 indexed citations
2.
Mirshahvalad, Seyed Ali, Mohsen Beheshti, Ur Metser, et al.. (2025). Theranostic: A Primer for Radiologists. Canadian Association of Radiologists Journal. 77(1). 202–211. 1 indexed citations
3.
Li, Yuancheng, Xiaojun Wang, Xingchao Liu, et al.. (2024). Adequate cumulative exposure to tacrolimus and low tacrolimus variability decrease the incidence of biliary complications after liver transplantation. International Immunopharmacology. 128. 111461–111461. 2 indexed citations
4.
Barua, Reeta, Mengqi Li, Di Jiang, et al.. (2024). Clinical variables associated with immune checkpoint inhibitor outcomes in patients with metastatic urothelial carcinoma: a multicentre retrospective cohort study. BMJ Open. 14(3). e081480–e081480. 2 indexed citations
5.
Hussain, Maha, Masha Kocherginsky, Parminder Singh, et al.. (2024). A pilot study of tazemetostat and pembrolizumab in advanced urothelial carcinoma (ETCTN 10183).. Journal of Clinical Oncology. 42(16_suppl). 4574–4574. 2 indexed citations
6.
Stewart, David J., Sandeep Sehdev, Vishal Navani, et al.. (2024). New Anticancer Drugs: Reliably Assessing “Value” While Addressing High Prices. Current Oncology. 31(5). 2453–2480. 5 indexed citations
7.
Mittal, Abhenil, Sara Moore, Vishal Navani, et al.. (2024). What Is Ailing Oncology Clinical Trials? Can We Fix Them?. Current Oncology. 31(7). 3738–3751. 3 indexed citations
8.
Jiang, Di, et al.. (2024). Experiences of patient delay among lung cancer patients in South China. BMC Cancer. 24(1). 1527–1527. 3 indexed citations
9.
Jiang, Di, Hao‐Wen Sim, Lillian L. Siu, et al.. (2023). Plasma Cetuximab Concentrations Correlate With Survival in Patients With Advanced KRAS Wild Type Colorectal Cancer. Clinical Colorectal Cancer. 22(4). 457–463.
10.
11.
Sanabria‐Salas, María Carolina, et al.. (2023). FLCN-Driven Functional Adrenal Cortical Carcinoma with High Mitotic Tumor Grade: Extending the Endocrine Manifestations of Birt-Hogg-Dubé Syndrome. Endocrine Pathology. 34(2). 257–264. 3 indexed citations
12.
Sayyid, Rashid K., Zachary Klaassen, Alejandro Berlín, et al.. (2023). Poly(adenosine diphosphate‐ribose) polymerase inhibitor combinations in first‐line metastatic castrate‐resistant prostate cancer setting: a systematic review and m eta‐analysis. British Journal of Urology. 132(6). 619–630. 11 indexed citations
13.
Jiang, Di, Chuan-Peng Zhang, Lei Li, et al.. (2023). Association between the expression levels of ADAMTS16 and BMP2 and tumor budding in hepatocellular carcinoma. Oncology Letters. 25(6). 256–256.
14.
Mittal, Abhenil, Srikala S. Sridhar, Michael Ong, & Di Jiang. (2023). Triplet Therapy in Metastatic Castrate Sensitive Prostate Cancer (mCSPC)—A Potential New Standard of Care. Current Oncology. 30(4). 4365–4378. 4 indexed citations
15.
Yu, Wen, et al.. (2022). A saponin from astragalus promotes pancreatic ductal organoids differentiation into insulin-producing cells. Phytomedicine. 102. 154190–154190. 8 indexed citations
16.
Chen, Rui, Ting Chen, Tianqi Wang, et al.. (2020). Tongmai Yangxin pill reduces myocardial no-reflow by regulating apoptosis and activating PI3K/Akt/eNOS pathway. Journal of Ethnopharmacology. 261. 113069–113069. 20 indexed citations
17.
Jiang, Di, Scott North, Christina Canil, et al.. (2020). Current Management of Localized Muscle-Invasive Bladder Cancer: A Consensus Guideline from the Genitourinary Medical Oncologists of Canada. Bladder Cancer. 6(3). 363–392. 2 indexed citations
18.
Jiang, Di, Alejandro Berlín, Lesley Moody, et al.. (2020). Transitioning to a New Normal in the Post-COVID Era. Current Oncology Reports. 22(7). 73–73. 12 indexed citations
19.
Chan, James, et al.. (2019). Building a CTU Orientation Handbook iPad® application for first-year residents. Europe PMC (PubMed Central). 1 indexed citations
20.
Rosseau, Gail, Julian E. Bailes, Rolando F. Del Maestro, et al.. (2013). The Development of a Virtual Simulator for Training Neurosurgeons to Perform and Perfect Endoscopic Endonasal Transsphenoidal Surgery. Neurosurgery. 73(suppl_1). S85–S93. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael H. Rosenthal Breakdown of academic impact, for papers by Huanyu Chen Breakdown of academic impact, for papers by Roni Shouval Breakdown of academic impact, for papers by Raffaele De Luca Breakdown of academic impact, for papers by Yuxuan Wu Breakdown of academic impact, for papers by Fei Xiong Breakdown of academic impact, for papers by Qingwei Zhang Breakdown of academic impact, for papers by Wei Fan Breakdown of academic impact, for papers by Junya Furukawa Breakdown of academic impact, for papers by Frank Kroschinsky
Rankless by CCL
2026